86 related articles for article (PubMed ID: 9470934)
1. High-dose ranitidine is ineffective in the treatment of psoriasis.
Cetin L; Yilmaz E; Alpsoy E; Başaran E
Br J Dermatol; 1997 Dec; 137(6):1021-2. PubMed ID: 9470934
[No Abstract] [Full Text] [Related]
2. Ranitidine does not affect psoriasis: a multicenter, double-blind, placebo-controlled study.
Zonneveld IM; Meinardi MM; Karlsmark T; Johansen UB; Kuiters GR; Hamminga L; Staberg B; van't Veen AJ; Bossuyt PM; van Niel JC; Bos JD
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):932-4. PubMed ID: 9204057
[TBL] [Abstract][Full Text] [Related]
3. Systemic high-dose ranitidine in the treatment of psoriasis: an open prospective clinical trial.
Kristensen JK; Petersen LJ; Hansen U; Nielsen H; Skov PS; Nielsen HJ
Br J Dermatol; 1995 Dec; 133(6):905-8. PubMed ID: 8547042
[TBL] [Abstract][Full Text] [Related]
4. [Clinical effect of ranitidine in psoriasis. An open prospective study].
Nielsen HJ; Kristensen JK; Hansen U; Nielsen HI; Skov PS; Petersen LM
Ugeskr Laeger; 1997 Jan; 159(5):598-600. PubMed ID: 9045450
[TBL] [Abstract][Full Text] [Related]
5. Studies on mast cells and histamine release in psoriasis: the effect of ranitidine.
Petersen LJ; Hansen U; Kristensen JK; Nielsen H; Skov PS; Nielsen HJ
Acta Derm Venereol; 1998 May; 78(3):190-3. PubMed ID: 9602224
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacodynamics and clinical adverse effects of mivacurium. The effect of oral premedication with H1/H2 antagonists].
Mayer M; Doenicke A; Nebauer AE; Rosenberger C; Lorenz W; Peter K
Anaesthesist; 1993 Sep; 42(9):592-6. PubMed ID: 8105716
[TBL] [Abstract][Full Text] [Related]
7. Roxatidine in duodenal ulcer.
Habibullah CM; Habeeb MA; Singh SP
J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
[TBL] [Abstract][Full Text] [Related]
8. A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn.
Rodriguez-Stanley S; Ciociola AA; Zubaidi S; Proskin HM; Miner PB
Aliment Pharmacol Ther; 2004 Nov; 20(9):975-82. PubMed ID: 15521845
[TBL] [Abstract][Full Text] [Related]
9. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.
Kahrilas PJ; Fennerty MB; Joelsson B
Am J Gastroenterol; 1999 Jan; 94(1):92-7. PubMed ID: 9934737
[TBL] [Abstract][Full Text] [Related]
10. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
11. [Symptomatic treatment of dyspepsia in patients with digestive system diseases].
Tkachev AV
Eksp Klin Gastroenterol; 2006; (6):56-60. PubMed ID: 17612097
[No Abstract] [Full Text] [Related]
12. Comparison of the effects of oral famotidine and ranitidine on gastric volume and pH.
Dubin SA; Silverstein PI; Wakefield ML; Jense HG
Anesth Analg; 1989 Nov; 69(5):680-3. PubMed ID: 2572186
[No Abstract] [Full Text] [Related]
13. Ranitidine as adjuvant treatment in colorectal cancer.
Nielsen HJ; Christensen IJ; Moesgaard F; Kehlet H;
Br J Surg; 2002 Nov; 89(11):1416-22. PubMed ID: 12390384
[TBL] [Abstract][Full Text] [Related]
14. Ranitidine therapy for recalcitrant warts in adults: a preliminary study.
Karaman G; Sendur N; Sevk E
J Eur Acad Dermatol Venereol; 2001 Sep; 15(5):495-6. PubMed ID: 11763407
[No Abstract] [Full Text] [Related]
15. Comparison of 150 mg nizatidine BID or 300 mg at bedtime, and 150 mg ranitidine BID in the treatment of gastric ulcer--an 8-week randomized, double-blind multicentre study.
Di Mario F; Battaglia G; Naccarato R; D'Angelo A; Saggioro A; Da Broi GL; Vezzadini P; Bianchi Porro G
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():62-5. PubMed ID: 1982108
[TBL] [Abstract][Full Text] [Related]
16. [Nizatidine versus ranitidine in the treatment of acute duodenal ulcer. Comparison of 300 mg nizatidine and 300 mg ranitidine in a single evening dose].
Arnold R; Beckenbach P; Bock H; Bormann R; Daake H; Dammann HG; Du Bosque G; Fürer M; Geiter B; Hebbeln H
Fortschr Med; 1989 Jul; 107(21):467-70. PubMed ID: 2570012
[TBL] [Abstract][Full Text] [Related]
17. 24 hour intragastric acidity and single night-time dose of three H-2-blockers.
Dammann HG; Müller P; Simon B
Lancet; 1983 Nov; 2(8358):1078. PubMed ID: 6138616
[No Abstract] [Full Text] [Related]
18. Single dose oral ranitidine improves MRCP image quality: a double-blind study.
Bowes MT; Martin DF; Melling A; Roberts D; Laasch HU; Sukumar S; Morris J
Clin Radiol; 2007 Jan; 62(1):53-7. PubMed ID: 17145264
[TBL] [Abstract][Full Text] [Related]
19. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection.
Jeppesen PB; Staun M; Tjellesen L; Mortensen PB
Gut; 1998 Dec; 43(6):763-9. PubMed ID: 9824602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
